Publications by authors named "Philippe Colucci"

Claim this Profile
R
Revisiting FDA's 1995 Guidance on Bioequivalence Establishment of Topical Dermatologic Corticosteroids: New Research Based Recommendations.
Deniz Ozdin, Naveen Sharma, Jorge Lujan-Zilbermann, Philippe Colucci, Isadore Kanfer

J Pharm Pharm Sci· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Food on the Pharmacokinetics of Single- and Multiple-Dose Hydrocodone Extended Release in Healthy Subjects.
Mary Bond, Laura Rabinovich-Guilatt, Sally Selim, Mona Darwish, William Tracewell, Philippe Colucci

Clin Drug Investig· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Review of the Pharmacokinetics of Levothyroxine for the Treatment of Hypothyroidism.
Philippe Colucci, Corinne Seng Yue, Murray Ducharme, Salvatore Benvenga

Eur Endocrinol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How critical is the duration of the sampling scheme for the determination of half-life, characterization of exposure and assessment of bioequivalence?
Philippe Colucci, Jacques Turgeon, Murray P Ducharme

J Pharm Pharm Sci· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of different population pharmacokinetic algorithms.
Philippe Colucci, Julie Grenier, Corinne Seng Yue, Jacques Turgeon, Murray P Ducharme

Ther Drug Monit· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic equivalence of a levothyroxine sodium soft capsule manufactured using the new food and drug administration potency guidelines in healthy volunteers under fasting conditions.
Philippe Colucci, Pina D'Angelo, Giuseppe Mautone, Claudia Scarsi, Murray P Ducharme

Ther Drug Monit· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple-dose pharmacokinetic behavior of elvucitabine, a nucleoside reverse transcriptase inhibitor, administered over 21 days with lopinavir-ritonavir in human immunodeficiency virus type 1-infected subjects.
Philippe Colucci, John C Pottage, Heather Robison, Jacques Turgeon, Dirk Schürmann

Antimicrob Agents Chemother· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of a single dose of ritonavir on the pharmacokinetic behavior of elvucitabine, a nucleoside reverse transcriptase inhibitor, administered in healthy volunteers.
Philippe Colucci, John C Pottage, Heather Robison, Jacques Turgeon, Murray P Ducharme

Antimicrob Agents Chemother· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with metastatic breast carcinoma.
Francisco J Esteva, Edgardo Rivera, Massimo Cristofanilli, Vicente Valero, Melanie Royce, Philippe Colucci

Cancer· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis